共 13 条
[1]
Antithrom-botic effects of recombinant hirudin in experimen-tal angioplasty and intravascular thrombolysis. Kaiser B,Simon A,Markwardt F. Thrombosis and Haemostasis . 1990
[2]
Prevention ofexperimental coronary thrombosis by hirudin. Bucha E,Nowak G,Markwardt F. Folia Haematologica . 1988
[3]
Haemostasis[P]. 英国专利:GB0300934D0,2003-02-12
[4]
A comparativestudy of recombinant hirudin and standard heparinin the Wessler model. Bara L,Bloch MF,Samama MM. Thrombosis Research . 1992
[5]
Studies onantithrombotic effects of recombinant hirudin. Markwardt F,Kaiser B,Nowak G. Thrombosis Research . 1989
[6]
Hirudin inhaemodialysis. Bucha E,Markwardt F,Nowak G. Thrombosis Research . 1990
[7]
Recom-binant desulphato-hirudin (CGP 39393 ): anti-coagulant and antithrombotic properties in vivo. Talbot MD,Ambler J,Butler KD,et al. Thrombosis and Haemostasis . 1989
[8]
Clinico-pharmacological studies with recombinanthirudin. Markwardt F,Nowak G,Sturzebechet J,et al. Thrombosis Research . 1988
[9]
Comparison ofhirudin and heparin as adjuncts to streptokinasethrombolysis in a canine model of coronarythrombosis. Rigel DF,Olson RW,Lappe RW. Circulation Research . 1993
[10]
The development of hirudin as anantithrombotic drug. Markwardt F. Thrombosis Research . 1994